Wolfram E. Samlowski
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 57
- Cancer Immunotherapy and Biomarkers 18
- Cutaneous Melanoma Detection and Management 15
- CAR-T cell therapy research 9
-
- Melanoma and MAPK Pathways 10
- Co-authors
- John R. McGregor (18 shared papers)John B. Hibbs (5 shared papers)Sancy A. Leachman (9 shared papers)Raymond A. Daynes (11 shared papers)Chang‐Yeol Yim (7 shared papers)Steven O’Day (9 shared papers)Neil R. Bastian (6 shared papers)Evan M. Hersh (4 shared papers)
- Journals
- Journal of Clinical Oncology (31 papers)Cancer (10 papers)Investigational New Drugs (8 papers)Journal of Immunotherapy (7 papers)Cellular Immunology (7 papers)
- Partner nations
- United StatesSouth KoreaCanada
In The Last Decade
Wolfram E. Samlowski
157 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 124
- Oncology 1.5k
- Immunology 818
- Cancer Research 315
- Hematology 239
- Pulmonary and Respiratory Medicine 606
Countries citing papers authored by Wolfram E. Samlowski
This map shows the geographic impact of Wolfram E. Samlowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfram E. Samlowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfram E. Samlowski more than expected).
Fields of papers citing papers by Wolfram E. Samlowski
This network shows the impact of papers produced by Wolfram E. Samlowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfram E. Samlowski. The network helps show where Wolfram E. Samlowski may publish in the future.
Co-authors
The 25 scholars most cited alongside Wolfram E. Samlowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 252 | |
| 2 | 2003 | 198 | |
| 3 | 2005 | 118 | |
| 4 | 2009 | 118 | |
| 5 | 2009 | 103 | |
| 6 | Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers. | 1993 | 101 |
| 7 | 1982 | 100 | |
| 8 | 1994 | 97 | |
| 9 | 2007 | 91 | |
| 10 | 1994 | 84 | |
| 11 | 1991 | 81 | |
| 12 | 2005 | 80 | |
| 13 | 2009 | 80 | |
| 14 | 2000 | 79 | |
| 15 | 2007 | 79 | |
| 16 | 2007 | 72 | |
| 17 | 1986 | 71 | |
| 18 | 2011 | 69 | |
| 19 | 1999 | 68 | |
| 20 | 2010 | 65 |
About Wolfram E. Samlowski
Wolfram E. Samlowski is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Immunology, having authored 161 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Cutaneous Melanoma Detection and Management (15 papers), Brain Metastases and Treatment (14 papers), Cancer Genomics and Diagnostics (13 papers), Nitric Oxide and Endothelin Effects (12 papers), Renal cell carcinoma treatment (12 papers), Melanoma and MAPK Pathways (10 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (818 citations), Cancer Research (315 citations), Hematology (239 citations) and Pulmonary and Respiratory Medicine (606 citations). Wolfram E. Samlowski has collaborated with scholars based in United States, South Korea and Canada. Frequent co-authors include John R. McGregor, John B. Hibbs, Sancy A. Leachman, Raymond A. Daynes, Chang‐Yeol Yim, Steven O’Day, Neil R. Bastian, Evan M. Hersh, Kenneth M. Boucher and Lee D. Cranmer. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Investigational New Drugs, Journal of Immunotherapy and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.